Additional analyses of DESTINY-Breast03 trial of ENHERTU and updated results from triple negative breast cancer cohort of TROPION-PanTumor01 trial of datopotamab deruxtecan to be highlighted Daiichi
ASCO Plenary: PARPi prevents disease recurrence in BRCA-mutated high-risk, early stage breast cancer vhio.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vhio.net Daily Mail and Mail on Sunday newspapers.